Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05904132
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-22
First Post:
2023-05-22
Brief Title:
Individual Closed-Loop Neuromodulation Therapy for Alzheimers Disease
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
Individual Closed-Loop Neuromodulation Therapy for Alzheimers Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation tACS to study patients with symptoms of mild cognitive impairment which is likely due to Alzheimers disease or another form of dementia AD-MCI Patients will undergo an EEG and complete some questionnaires and computer tasks during each study visit The project has the following aims and hypotheses 1 To determine the impact of closed-loop 40 Hz tACS on the entrainment of natural gamma rhythms in patients with AD-MCI 2 To determine the impact of closed-loop 40 Hz tACS on cognitive performance in patients with AD-MCI and 3 To assess the relationship between baseline neurodegenerative burden and impact of tACS exploratory
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
True
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None